Advanced Search

Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2016 June;107(3 Suppl 1) > Minerva Medica 2016 June;107(3 Suppl 1):1-6



A Journal on Internal Medicine

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


Minerva Medica 2016 June;107(3 Suppl 1):1-6



Towards a multi-dimensional approach to COPD

Alessandro ZANFORLIN 1, Claudio SORINO 2, Giuseppe F. SFERRAZZA PAPA 3

1 Multidisciplinary Medical Department, San Luca Hospital, Trecenta, Rovigo, Italy; 2 Department of Internal Medicine, University of Palermo, V. Cervello Hospital, Villa Sofia Hospitals, Palermo, Italy; 3 Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano, Milan, Italy

Chronic obstructive pulmonary disease (COPD) is the third leading cause of mortality worldwide. Clinical features of the disease include exertional dyspnea and chronic cough, while persistent airflow obstruction detected at spirometry is the defining element of the disease. Notably, subjects with smoke exposure and symptoms, but normal FEV1/FVC ratio (previously classified as “stage 0” by the GOLD classification), are not considered affected and do not require treatment according to guidelines. The recent GeneCOPD study suggested that a proportion of this population might present significant radiological features of respiratory disease. This commentary article focuses on the possible future role of chest imaging, including ultrasound of the respiratory muscles, integrated with additional functional tests, such as body plethysmography and diffusing capacity for carbon monoxide of the lungs (DLCO), in a multidimensional assessment of COPD.

language: English


top of page